Cat.#: BBM-3C-042
Description | Collagen Type IV (Human Placenta) from Human Cell Culture from Ace Therapeutics is derived from human placenta and is highly purified native, type IV collagen. |
Source | Human placenta |
Size | 100 μg |
Form | Liquid |
Purity | ≥90% (SDS-PAGE) |
Sterility | Passed sterility test for bacteria and fungi. |
Storage | −20°C |
Shipping | Wet ice |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-3C-040 | Collagen Type IV from Human Cell Culture |
Collagen Type IV from Human Cell Culture from Ace Therapeutics is derived from human fibroblasts and epithelial cells in a co-culture system, which creates an in vitro ECM (extracellular matrix) and serves as an excellent biological scaffold for three-dimensional cell culture.
|
inquiry |
BBM-3C-045 | Collagen from Human Placenta |
Collagen from Human Placenta is supplied as a 0.5 M acetic acid solution. It can be used to coat tissue culture surfaces to promote cell attachment
|
inquiry |
BBM-3C-063 | Collagen Gel Culturing Kit |
Collagen Gel Culturing Kit from Ace Therapeutics is a ready-to-use kit for form gel. This kit consists of the all reagents required for the experiment, including cellmatrix type I-A, Ham F-12 culture medium, MEM Hanks culture medium, and reconstitution buffer.
|
inquiry |
BBM-3C-050 | Bovine Collagen Type I |
Bovine Collagen Type I from Ace Therapeutics is a purified collagen derived from bovine tissue. The native collagen sequence contained in the preparation is missing or shortened since this product has been treated with pepsin.
|
inquiry |
BBM-3C-070 | Cultrex Bovine Collagen I |
Cultrex Bovine Collagen I from Ace Therapeutics is a purified stromal extracellular matrix protein from fetal bovine extensor tendons and is pepsin-treated to remove telopeptides. This product promotes cell adhesion for cell and tissue culture.
|
inquiry |
BBM-3C-022 | Mouse Collagen Type I and III, 5 mg |
Mouse Collagen Type I and III, 5 mg from Ace Therapeutics is purified from rom tail tendons of the mouse.
Type I collagen is the most abundant collagen and is found in connective tissues including tendons, ligaments, dermis, and blood vessels. Type III collagen is the second most abundant collagen in tissues and is found most commonly in tissues exhibiting elastic properties such as skin, lungs, intestinal walls, and walls of blood vessels, which resembles other fibrillar collagens in structure and function.
|
inquiry |
BBM-3C-024 | Rat Collagen Type I and III, 10 mg |
Rat Collagen Type I and III, 10 mg from Ace Therapeutics is purified from rat tissue.
Type I collagen is the most abundant collagen and is found in connective tissues including tendons, ligaments, dermis, and blood vessels. Type III collagen is the second most abundant collagen in tissues and is found most commonly in tissues exhibiting elastic properties such as skin, lungs, intestinal walls, and walls of blood vessels, which resembles other fibrillar collagens in structure and function.
|
inquiry |
BBM-3C-068 | Cultrex Mouse Collagen IV |
Cultrex Mouse Collagen IV from Ace Therapeutics is a stromal extracellular matrix protein purified from a murine engelbreth-holm-swarm (EHS) tumor. This product can promote cell adhesion in cell and tissue cultures as well as be used as a hydrogel or thin coating for tissue culture vessels.
|
inquiry |
BBM-3C-044 | Collagen, Type I Solution from Rat Tail |
Collagen, Type I Solution from Rat Tail from Ace Therapeutics is derived from rat tail, which used in tissue engineering especially in the generation of 3-D scaffolds based gels.
|
inquiry |
BBM-3C-016 | Bovine Collagen Type VI, Lyophilized, 0.1mg |
Bovine Collagen Type VI, Lyophilized, 0.1mg from Ace Therapeutics is purified from the bovine placenta.
The product is the major collagenous component of microfibrils in elastic fibers and in a larger variety of tissues, which consist of two α-chains of ca.
|
inquiry |
We are committed to accelerating progress in stroke research and drug development.